CeriBell Inc (CBLL)

Currency in USD
12.91
+0.33(+2.62%)
Closed·
After Hours
12.71-0.20(-1.55%)
·
CBLL Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CBLL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.6813.29
52 wk Range
10.0132.75
Key Statistics
Prev. Close
12.58
Open
12.69
Day's Range
12.68-13.29
52 wk Range
10.01-32.75
Volume
636.79K
Average Volume (3m)
340.72K
1-Year Change
-
Book Value / Share
4.76
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CBLL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
30.00
Upside
+132.38%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

CeriBell Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

CeriBell Inc Company Profile

CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting. It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders to record and store EEG signals generated by the headband. In addition, the company provides Clarity, an AI-powered seizure detection algorithm. Further, it operates Ceribell EEG portal, a cloud-based secured portal that enables real-time remote access to a patient’s EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

CeriBell Inc Earnings Call Summary for Q2/2025

  • Revenue up 38% YoY to $21.2M; net loss of $13.6M ($0.38/share). Stock dips 0.85% after hours to $15.23.
  • Full-year 2025 revenue guidance raised to $85-$88M, projecting 30-34% annual growth.
  • Gross margin improves to 88%; company aims to maintain mid-80% range through 2026.
  • Expansion plans include increased territory coverage and development of delirium detection algorithm.
  • CEO emphasizes mission to enhance patient care through expanded EEG access, making it a vital sign.
Last Updated: 05/08/2025, 22:54
Read Full Transcript

Compare CBLL to Peers and Sector

Metrics to compare
CBLL
Peers
Sector
Relationship
P/E Ratio
−9.6x−3.6x−0.5x
PEG Ratio
−0.14−0.200.00
Price/Book
2.7x2.2x2.6x
Price / LTM Sales
6.1x2.1x3.3x
Upside (Analyst Target)
140.1%42.7%43.4%
Fair Value Upside
Unlock9.8%7.1%Unlock

Analyst Ratings

7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 30.00
(+132.38% Upside)

Earnings

Latest Release
Aug 05, 2025
EPS / Forecast
-0.38 / --
Revenue / Forecast
21.20M / --
EPS Revisions
Last 90 days

CBLL Income Statement

People Also Watch

2.840
ABSI
-2.74%
138.66
KRYS
+1.88%
17.62
BEAM
-1.34%
11.16
DYN
-0.27%
16.42
ARWR
+2.24%

FAQ

What Stock Exchange Does CeriBell Trade On?

CeriBell is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for CeriBell?

The stock symbol for CeriBell is "CBLL."

What Is the CeriBell Market Cap?

As of today, CeriBell market cap is 473.33M.

What Is CeriBell's Earnings Per Share (TTM)?

The CeriBell EPS (TTM) is -1.81.

From a Technical Analysis Perspective, Is CBLL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has CeriBell Stock Split?

CeriBell has split 0 times.

How Many Employees Does CeriBell Have?

CeriBell has 281 employees.

What is the current trading status of CeriBell (CBLL)?

As of 09 Aug 2025, CeriBell (CBLL) is trading at a price of 12.91, with a previous close of 12.58. The stock has fluctuated within a day range of 12.68 to 13.29, while its 52-week range spans from 10.01 to 32.75.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.